AKT1 and ovarian carcinoma: Mutations in Akt1 that result in constitutive activation or elevated Akt1 expression have been implicated in a wide range of cancers, including colorectal, breast, prostate, lung, pancreatic, liver, and ovarian cancers as well as in leukemia and glioblastomas [9], [10], [11].